BMYMP Bristol-Myers Squibb Co. $BMYMP Company Overview
Stock Message Board http://investorshangout.com/search?q=BMYMP&am...mp;yt1=Go!
Last Updated: Monday, March 31, 2014 02:55:32 AM
Bristol-Myers Squibb Co. BMYMP Current Price and Quotes
Last Price 901.56
Previous Close 901.56 Open N/A
Daily Range N/A - N/A 52wk Range 997.10 - 829.80
Volume 0 Dividend 2.00
Average Vol (3m) 17 Yield 0.221838
Bristol-Myers Squibb Co. BMYMP
Company Information
345 Park Avenue
New York, NY 10154
Website: http://www.bms.com
Phone: 212-546-4000
Email: ranya.dajani@bms.com
Bristol-Myers Squibb Co. BMYMP
Not Available
Bristol-Myers Squibb Co. BMYMP
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Dec 31, 2013 10-K
CIK 0000014272
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
James M. Cornelius Interim CEO
Sandra Leung Secretary
Company Directors
Not Available
Company Notes
Formerly=Bristol-Myers Co. to 10-89
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
Bristol-Myers Squibb Co. BMYMP
BMYMP Security Details Other Company Securities
Share Structure
Market Value1 Not Available
Shares Outstanding Not Available
Float Not Available
Authorized Shares Not Available
Par Value 1
Shareholders
Shareholders of Record Not Available
Corporate Actions
Ex. Date Record Date Pay Date
Dividend (0.50) May 07, 2014 May 09, 2014 Jun 02, 2014
Dividend (0.50) Feb 05, 2014 Feb 07, 2014 Mar 03, 2014
Dividend (0.50) Nov 06, 2013 Nov 08, 2013 Dec 02, 2013
Security Notes
Note = Delisted from NYSE on 6-10-13
Short Selling Data
Short Interest 0 (-100%)
Jun 28, 2013
Significant Failures to Deliver No
Transfer Agent(s)
BNYMellon Shareowner Services
Bristol-Myers Squibb Co. BMYMP Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 16,385,000 17,621,000 21,244,000 19,484,000
Cost of Revenue 4,619,000 4,610,000 5,598,000 5,277,000
Gross Profit 11,766,000 13,011,000 15,646,000 14,207,000
Operating Expenses
Research and Development 3,731,000 3,904,000 3,839,000 3,566,000
Sales, General and Admin. 4,939,000 5,017,000 5,160,000 4,663,000
Non-Recurring Items - 1,830,000 - -
Other - - - -
Operating Income 3,096,000 2,260,000 6,647,000 5,978,000
Income From Continuing Operations
Add'l Income/Expense Items (205,000) 80,000 334,000 93,000
Earnings Before Interest and Tax 2,891,000 2,340,000 6,981,000 6,071,000
Interest Expense - - - -
Earnings Before Tax 2,891,000 2,340,000 6,981,000 6,071,000
Income Tax 311,000 (161,000) 1,721,000 1,558,000
Minority Interest 17,000 541,000 1,551,000 1,411,000
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 2,563,000 1,960,000 3,709,000 3,102,000
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 2,563,000 1,960,000 3,709,000 3,102,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 2,563,000 1,960,000 3,709,000 3,102,000
Bristol-Myers Squibb Co. BMYMP Recent News
Mar 27, 2014 In A Subanalysis, The Benefits Of Eliquis(R) (apixaban) Vs. Warfarin In Reducing The Risk Of Stroke In Patients With Nonvalvular Atrial Fibrillation Were Consistent, Regardless Of Blood Pressure Control(1)
Mar 26, 2014 Pharmaceutical Executive to Unveil Brand of the Year Award Recipients at iPharma 2014: CBI's Marketing Innovation Summit
Mar 25, 2014 Five Prime Therapeutics Announces Fourth Quarter and Fiscal 2013 Financial Results
Mar 25, 2014 Tocagen Names Jamey Skillings, M.D., Chief Medical Officer
Mar 24, 2014 Bristol-Myers Squibb to Present Data for Daclatasvir in Multiple Investigational All-oral Combinations across Hepatitis C Genotypes at The International Liver Congress(TM)
Mar 21, 2014 FDA Approvals, Financial Highlights, Restated Treatment Indications, and Updates on Product Pipelines - Analyst Notes on Bristol-Myers Squibb, Galena, Teleflex, GW Pharmaceuticals, and CytRx
Mar 20, 2014 Trace One Names Mark Martini as Vice President of North America to Lead Sales and Customer Development
Mar 19, 2014 Portola Pharmaceuticals Initiates Phase 3 Study of Andexanet Alfa, Potential First-in-Class Factor Xa Inhibitor Reversal Agent, Under Accelerated Approval Pathway
Mar 19, 2014 Health Care Stocks Review -- Research on Bristol-Myers Squibb, Johnson & Johnson, Merck & Co. and Eli Lilly
Mar 17, 2014 Five Prime Therapeutics and Bristol-Myers Squibb Sign Collaboration Agreement to Discover Novel Immuno-Oncology Therapies for Two Immune Checkpoint Pathways
1
2
3
4
5
6
next >
BMYMP Bristol-Myers Squibb Co. Research DD Guide
Stock Message Board http://investorshangout.com/search?q=BMYMP&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/BMYMP/quote
Stock Chart http://www.otcmarkets.com/stock/BMYMP/chart
Company Info http://www.otcmarkets.com/stock/BMYMP/company-info
Recent News http://www.otcmarkets.com/stock/BMYMP/news
Financials http://www.otcmarkets.com/stock/BMYMP/financials
Filings and Disclosure http://www.otcmarkets.com/stock/BMYMP/filings
Short Sales http://www.otcmarkets.com/stock/BMYMP/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/BMYMP/insider-transactions
Research Reports http://www.otcmarkets.com/stock/BMYMP/research
Summary http://finance.yahoo.com/q?s=BMYMP
Historical Prices http://finance.yahoo.com/q/hp?s=BMYMP+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=BMYMP
Basic Chart http://finance.yahoo.com/q/bc?s=BMYMP+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BMYMP+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=BMYMP+Headlines
Press Releases http://finance.yahoo.com/q/p?s=BMYMP+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=BMYMP+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=BMYMP+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=BMYMP+Industry
Major Holders http://finance.yahoo.com/q/mh?s=BMYMP+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=BMYMP+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=BMYMP+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=BMYMP
Balance Sheet http://finance.yahoo.com/q/bs?s=BMYMP
Cash Flow http://finance.yahoo.com/q/cf?s=BMYMP+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/BMYMP
Market Watch http://www.marketwatch.com/investing/stock/BMYMP
Bloomberg http://www.bloomberg.com/quote/BMYMP:US
Morningstar http://quotes.morningstar.com/stock/s?t=BMYMP
Bussinessweek http://investing.businessweek.com/research/st...cker=BMYMP
Barchart http://www.barchart.com/quotes/stocks/BMYMP
OTC Short Report http://otcshortreport.com/index.php?index=BMYMP
Investopedia http://www.investopedia.com/markets/stocks/BMYMP/?wa=0
Stock Message Board http://investorshangout.com/search?q=BMYMP&am...mp;yt1=Go!
Last Updated: Monday, March 31, 2014 02:55:32 AM
Bristol-Myers Squibb Co. BMYMP Current Price and Quotes
Last Price 901.56
Previous Close 901.56 Open N/A
Daily Range N/A - N/A 52wk Range 997.10 - 829.80
Volume 0 Dividend 2.00
Average Vol (3m) 17 Yield 0.221838
Bristol-Myers Squibb Co. BMYMP
Company Information
345 Park Avenue
New York, NY 10154
Website: http://www.bms.com
Phone: 212-546-4000
Email: ranya.dajani@bms.com
Bristol-Myers Squibb Co. BMYMP
Not Available
Bristol-Myers Squibb Co. BMYMP
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Dec 31, 2013 10-K
CIK 0000014272
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
James M. Cornelius Interim CEO
Sandra Leung Secretary
Company Directors
Not Available
Company Notes
Formerly=Bristol-Myers Co. to 10-89
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
Bristol-Myers Squibb Co. BMYMP
BMYMP Security Details Other Company Securities
Share Structure
Market Value1 Not Available
Shares Outstanding Not Available
Float Not Available
Authorized Shares Not Available
Par Value 1
Shareholders
Shareholders of Record Not Available
Corporate Actions
Ex. Date Record Date Pay Date
Dividend (0.50) May 07, 2014 May 09, 2014 Jun 02, 2014
Dividend (0.50) Feb 05, 2014 Feb 07, 2014 Mar 03, 2014
Dividend (0.50) Nov 06, 2013 Nov 08, 2013 Dec 02, 2013
Security Notes
Note = Delisted from NYSE on 6-10-13
Short Selling Data
Short Interest 0 (-100%)
Jun 28, 2013
Significant Failures to Deliver No
Transfer Agent(s)
BNYMellon Shareowner Services
Bristol-Myers Squibb Co. BMYMP Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 16,385,000 17,621,000 21,244,000 19,484,000
Cost of Revenue 4,619,000 4,610,000 5,598,000 5,277,000
Gross Profit 11,766,000 13,011,000 15,646,000 14,207,000
Operating Expenses
Research and Development 3,731,000 3,904,000 3,839,000 3,566,000
Sales, General and Admin. 4,939,000 5,017,000 5,160,000 4,663,000
Non-Recurring Items - 1,830,000 - -
Other - - - -
Operating Income 3,096,000 2,260,000 6,647,000 5,978,000
Income From Continuing Operations
Add'l Income/Expense Items (205,000) 80,000 334,000 93,000
Earnings Before Interest and Tax 2,891,000 2,340,000 6,981,000 6,071,000
Interest Expense - - - -
Earnings Before Tax 2,891,000 2,340,000 6,981,000 6,071,000
Income Tax 311,000 (161,000) 1,721,000 1,558,000
Minority Interest 17,000 541,000 1,551,000 1,411,000
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 2,563,000 1,960,000 3,709,000 3,102,000
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 2,563,000 1,960,000 3,709,000 3,102,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 2,563,000 1,960,000 3,709,000 3,102,000
Bristol-Myers Squibb Co. BMYMP Recent News
Mar 27, 2014 In A Subanalysis, The Benefits Of Eliquis(R) (apixaban) Vs. Warfarin In Reducing The Risk Of Stroke In Patients With Nonvalvular Atrial Fibrillation Were Consistent, Regardless Of Blood Pressure Control(1)
Mar 26, 2014 Pharmaceutical Executive to Unveil Brand of the Year Award Recipients at iPharma 2014: CBI's Marketing Innovation Summit
Mar 25, 2014 Five Prime Therapeutics Announces Fourth Quarter and Fiscal 2013 Financial Results
Mar 25, 2014 Tocagen Names Jamey Skillings, M.D., Chief Medical Officer
Mar 24, 2014 Bristol-Myers Squibb to Present Data for Daclatasvir in Multiple Investigational All-oral Combinations across Hepatitis C Genotypes at The International Liver Congress(TM)
Mar 21, 2014 FDA Approvals, Financial Highlights, Restated Treatment Indications, and Updates on Product Pipelines - Analyst Notes on Bristol-Myers Squibb, Galena, Teleflex, GW Pharmaceuticals, and CytRx
Mar 20, 2014 Trace One Names Mark Martini as Vice President of North America to Lead Sales and Customer Development
Mar 19, 2014 Portola Pharmaceuticals Initiates Phase 3 Study of Andexanet Alfa, Potential First-in-Class Factor Xa Inhibitor Reversal Agent, Under Accelerated Approval Pathway
Mar 19, 2014 Health Care Stocks Review -- Research on Bristol-Myers Squibb, Johnson & Johnson, Merck & Co. and Eli Lilly
Mar 17, 2014 Five Prime Therapeutics and Bristol-Myers Squibb Sign Collaboration Agreement to Discover Novel Immuno-Oncology Therapies for Two Immune Checkpoint Pathways
1
2
3
4
5
6
next >
BMYMP Bristol-Myers Squibb Co. Research DD Guide
Stock Message Board http://investorshangout.com/search?q=BMYMP&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/BMYMP/quote
Stock Chart http://www.otcmarkets.com/stock/BMYMP/chart
Company Info http://www.otcmarkets.com/stock/BMYMP/company-info
Recent News http://www.otcmarkets.com/stock/BMYMP/news
Financials http://www.otcmarkets.com/stock/BMYMP/financials
Filings and Disclosure http://www.otcmarkets.com/stock/BMYMP/filings
Short Sales http://www.otcmarkets.com/stock/BMYMP/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/BMYMP/insider-transactions
Research Reports http://www.otcmarkets.com/stock/BMYMP/research
Summary http://finance.yahoo.com/q?s=BMYMP
Historical Prices http://finance.yahoo.com/q/hp?s=BMYMP+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=BMYMP
Basic Chart http://finance.yahoo.com/q/bc?s=BMYMP+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BMYMP+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=BMYMP+Headlines
Press Releases http://finance.yahoo.com/q/p?s=BMYMP+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=BMYMP+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=BMYMP+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=BMYMP+Industry
Major Holders http://finance.yahoo.com/q/mh?s=BMYMP+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=BMYMP+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=BMYMP+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=BMYMP
Balance Sheet http://finance.yahoo.com/q/bs?s=BMYMP
Cash Flow http://finance.yahoo.com/q/cf?s=BMYMP+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/BMYMP
Market Watch http://www.marketwatch.com/investing/stock/BMYMP
Bloomberg http://www.bloomberg.com/quote/BMYMP:US
Morningstar http://quotes.morningstar.com/stock/s?t=BMYMP
Bussinessweek http://investing.businessweek.com/research/st...cker=BMYMP
Barchart http://www.barchart.com/quotes/stocks/BMYMP
OTC Short Report http://otcshortreport.com/index.php?index=BMYMP
Investopedia http://www.investopedia.com/markets/stocks/BMYMP/?wa=0
